Related Experiment Video

Updated: Jul 3, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss

Riccardo Ruffoli1, Maria Anita Giambelluca, Maria Concetta Scavuzzo

  • 1Department of Human Morphology and Applied Biology, University of Pisa Via Roma, 55-56126 Pisa, Italy. r.ruffoli@med.unipi.it

Brain Research
|July 23, 2008
PubMed

Insights

Parkinson's disease often causes genital dysfunction and low testosterone. This study shows the neurotoxin MPTP causes similar testicular damage and testosterone loss in mice, creating a new Parkinson's disease model.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Toxicology

Background:

  • Genital dysfunction and testosterone deficiency are common non-motor symptoms in Parkinson's disease (PD).
  • The experimental reproduction of these symptoms using neurotoxins has not been previously investigated.

Purpose of the Study:

  • To investigate the testicular effects of the Parkinsonism-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
  • To establish an experimental model for studying PD-related genital dysfunction.

Main Methods:

  • Mice were treated with MPTP to induce Parkinsonism.
  • Testicular tissue and plasma testosterone levels were analyzed 7 days post-treatment.
  • Evaluated were dopamine depletion, Leydig cell morphology, mitochondrial integrity, tyrosine hydroxylase (TH) expression, and norepinephrine levels.

Main Results:

  • MPTP treatment caused significant nigrostriatal dopamine depletion and decreased plasma testosterone levels.
  • A marked loss of Leydig cells and severe mitochondrial degeneration were observed in the testes.
  • Reduced TH immunohistochemistry and protein, along with decreased testicular norepinephrine, were noted.

Conclusions:

  • MPTP administration in mice effectively models the testicular dysfunction and testosterone deficiency seen in Parkinson's disease.
  • This provides a novel experimental platform for understanding and potentially treating genital dysfunction in PD patients.

More Related Videos

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.